对新冠肺炎疫苗接种的认识和态度:印度卡纳塔克邦达尔瓦德的跨部门研究

S. Javali, Chandrakanth M. Math, M. Sunkad
{"title":"对新冠肺炎疫苗接种的认识和态度:印度卡纳塔克邦达尔瓦德的跨部门研究","authors":"S. Javali, Chandrakanth M. Math, M. Sunkad","doi":"10.1055/s-0042-1757739","DOIUrl":null,"url":null,"abstract":"A peculiar new disease, COVID-19 affecting the lungs, causing cough, and difficulty in breathing, has affected people in most countries. The disease, first noticed in the Wuhan province, moved to the entire world in a short period. There were a large number of people with mild symptoms, some with severe forms of the disease, and some in very severe stage, resulting in their death. In total, 425 million people suffered, 351 million fully recovered, and 6 million died worldwide. This sudden disease crisis has united every one across the globe to control and minimize the severity of the disease. Toward this goal, scientists, doctors, and researchers are engaged with studies on the disease, disease-causing viruses, treatment regimen, and some other developed vaccines to prevent the illness. In a routine standard procedure, inventing a new drug or vaccine takes a few years from thought to clinical trials. However, in the present day, technology has advanced so much that it has come up with answers in a short time. That is how we have a few vaccines against COVID-19 disease ready for use in an emergency. In all these ventures, strict procedures, protocols, ethical considerations, and regulatory requirements have been adhered to and only upon such satisfaction they have been released for use in the population. The governments have taken a decision to use these vaccines on their people. They have made widely dispersed information about vaccines available to people through popular media. The questions can be numerous: “has this information reached the grassroots level, have people understood the benefits and risks, is the information adequate to make informed consent to take the vaccines, whowill receive the vaccines first, given the limited supply.” There is a need for studies on all these issues from different parts of the geography, different culture, different ethnicity cutting across borders. The situation is peculiar, vaccine put up in short period, launched nationwide, what in the event of adverse side effects, what if sizeable population refuse vaccination? In any given scenario, there are persons with advanced age, disability, chronic disease, dependency internet surfers, rumor mongers, atheists who may flatly refuse to take the vaccine. If such persons are influential, they may induce others not to take the shots. In our observation of a group of health workers, few 1% refused fully, 5% pretended with lame excuse to take vaccine, and 12% were undecided. The Internet is a great leveler, and social media is rich with many experiences. In this context, one such effort in this direction is to identify the level of awareness and extent of attitude toward COVID-19 vaccinations in Northern Karnataka. There are studies from Bangladesh, the UAE, the Middle East region, Africa, and Europe suggesting adequate knowledge and a hostile attitude toward COVID-19 vaccines.1–8 We proposed and obtained permission for this study from our Institutional Research committee [IRC23/April2021]. We conducted a cross-sectional study from July to September,","PeriodicalId":53332,"journal":{"name":"Annals of the National Academy of Medical Sciences India","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Awareness and Attitudes toward COVID-19 Vaccinations: A Cross-Sectional Study in Dharwad, Karnataka, India\",\"authors\":\"S. Javali, Chandrakanth M. Math, M. Sunkad\",\"doi\":\"10.1055/s-0042-1757739\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A peculiar new disease, COVID-19 affecting the lungs, causing cough, and difficulty in breathing, has affected people in most countries. The disease, first noticed in the Wuhan province, moved to the entire world in a short period. There were a large number of people with mild symptoms, some with severe forms of the disease, and some in very severe stage, resulting in their death. In total, 425 million people suffered, 351 million fully recovered, and 6 million died worldwide. This sudden disease crisis has united every one across the globe to control and minimize the severity of the disease. Toward this goal, scientists, doctors, and researchers are engaged with studies on the disease, disease-causing viruses, treatment regimen, and some other developed vaccines to prevent the illness. In a routine standard procedure, inventing a new drug or vaccine takes a few years from thought to clinical trials. However, in the present day, technology has advanced so much that it has come up with answers in a short time. That is how we have a few vaccines against COVID-19 disease ready for use in an emergency. In all these ventures, strict procedures, protocols, ethical considerations, and regulatory requirements have been adhered to and only upon such satisfaction they have been released for use in the population. The governments have taken a decision to use these vaccines on their people. They have made widely dispersed information about vaccines available to people through popular media. The questions can be numerous: “has this information reached the grassroots level, have people understood the benefits and risks, is the information adequate to make informed consent to take the vaccines, whowill receive the vaccines first, given the limited supply.” There is a need for studies on all these issues from different parts of the geography, different culture, different ethnicity cutting across borders. The situation is peculiar, vaccine put up in short period, launched nationwide, what in the event of adverse side effects, what if sizeable population refuse vaccination? In any given scenario, there are persons with advanced age, disability, chronic disease, dependency internet surfers, rumor mongers, atheists who may flatly refuse to take the vaccine. If such persons are influential, they may induce others not to take the shots. In our observation of a group of health workers, few 1% refused fully, 5% pretended with lame excuse to take vaccine, and 12% were undecided. The Internet is a great leveler, and social media is rich with many experiences. In this context, one such effort in this direction is to identify the level of awareness and extent of attitude toward COVID-19 vaccinations in Northern Karnataka. There are studies from Bangladesh, the UAE, the Middle East region, Africa, and Europe suggesting adequate knowledge and a hostile attitude toward COVID-19 vaccines.1–8 We proposed and obtained permission for this study from our Institutional Research committee [IRC23/April2021]. We conducted a cross-sectional study from July to September,\",\"PeriodicalId\":53332,\"journal\":{\"name\":\"Annals of the National Academy of Medical Sciences India\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of the National Academy of Medical Sciences India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0042-1757739\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the National Academy of Medical Sciences India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1757739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

一种特殊的新疾病新冠肺炎影响肺部,导致咳嗽和呼吸困难,已影响到大多数国家的人们。这种疾病最初在武汉省被发现,并在短时间内传播到全世界。有很多人症状轻微,有些人病情严重,有些人处于非常严重的阶段,导致他们死亡。全世界共有4.25亿人患病,3.51亿人完全康复,600万人死亡。这场突如其来的疾病危机团结了全球所有人,以控制并将疾病的严重程度降至最低。为了实现这一目标,科学家、医生和研究人员正在研究这种疾病、致病病毒、治疗方案以及其他一些已开发的预防疾病的疫苗。在常规的标准程序中,发明一种新药或疫苗需要几年的时间从思考到临床试验。然而,在今天,技术进步如此之快,以至于在短时间内就找到了答案。这就是为什么我们有一些针对新冠肺炎疾病的疫苗可以在紧急情况下使用。在所有这些风险投资中,都遵守了严格的程序、协议、道德考虑和监管要求,只有在满足这些要求的情况下,它们才能在人群中使用。各国政府已决定在本国人民身上使用这些疫苗。他们通过大众媒体向人们提供了广泛传播的疫苗信息。问题可能很多:“这些信息是否到达基层,人们是否了解其益处和风险,这些信息是否足以让知情同意接种疫苗,在供应有限的情况下,谁将首先接种疫苗。”有必要从不同的地理、不同的文化、,跨越国界的不同种族。情况很特殊,疫苗在短时间内推出,在全国范围内推出,如果出现不良副作用,如果相当多的人拒绝接种疫苗,该怎么办?在任何特定的情况下,都有老年人、残疾人、慢性病患者、依赖性网络冲浪者、造谣者、无神论者可能会断然拒绝接种疫苗。如果这些人有影响力,他们可能会诱使其他人不要出手。在我们对一组卫生工作者的观察中,只有1%的人完全拒绝,5%的人以蹩脚的借口假装接种疫苗,12%的人犹豫不决。互联网是一个很好的平台,社交媒体有着丰富的经验。在这种情况下,这方面的一项努力是确定卡纳塔克邦北部对新冠肺炎疫苗接种的认识水平和态度程度。来自孟加拉国、阿联酋、中东地区、非洲和欧洲的研究表明,对新冠肺炎疫苗有足够的了解和敌对态度。1-8我们提出并获得了机构研究委员会的许可[IRC23/2021年4月]。我们在7月至9月进行了一项横断面研究,
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Awareness and Attitudes toward COVID-19 Vaccinations: A Cross-Sectional Study in Dharwad, Karnataka, India
A peculiar new disease, COVID-19 affecting the lungs, causing cough, and difficulty in breathing, has affected people in most countries. The disease, first noticed in the Wuhan province, moved to the entire world in a short period. There were a large number of people with mild symptoms, some with severe forms of the disease, and some in very severe stage, resulting in their death. In total, 425 million people suffered, 351 million fully recovered, and 6 million died worldwide. This sudden disease crisis has united every one across the globe to control and minimize the severity of the disease. Toward this goal, scientists, doctors, and researchers are engaged with studies on the disease, disease-causing viruses, treatment regimen, and some other developed vaccines to prevent the illness. In a routine standard procedure, inventing a new drug or vaccine takes a few years from thought to clinical trials. However, in the present day, technology has advanced so much that it has come up with answers in a short time. That is how we have a few vaccines against COVID-19 disease ready for use in an emergency. In all these ventures, strict procedures, protocols, ethical considerations, and regulatory requirements have been adhered to and only upon such satisfaction they have been released for use in the population. The governments have taken a decision to use these vaccines on their people. They have made widely dispersed information about vaccines available to people through popular media. The questions can be numerous: “has this information reached the grassroots level, have people understood the benefits and risks, is the information adequate to make informed consent to take the vaccines, whowill receive the vaccines first, given the limited supply.” There is a need for studies on all these issues from different parts of the geography, different culture, different ethnicity cutting across borders. The situation is peculiar, vaccine put up in short period, launched nationwide, what in the event of adverse side effects, what if sizeable population refuse vaccination? In any given scenario, there are persons with advanced age, disability, chronic disease, dependency internet surfers, rumor mongers, atheists who may flatly refuse to take the vaccine. If such persons are influential, they may induce others not to take the shots. In our observation of a group of health workers, few 1% refused fully, 5% pretended with lame excuse to take vaccine, and 12% were undecided. The Internet is a great leveler, and social media is rich with many experiences. In this context, one such effort in this direction is to identify the level of awareness and extent of attitude toward COVID-19 vaccinations in Northern Karnataka. There are studies from Bangladesh, the UAE, the Middle East region, Africa, and Europe suggesting adequate knowledge and a hostile attitude toward COVID-19 vaccines.1–8 We proposed and obtained permission for this study from our Institutional Research committee [IRC23/April2021]. We conducted a cross-sectional study from July to September,
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
19
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信